Skip to main content
Rocket Pharmaceuticals, Inc. (RCKT)
NASDAQ: RCKT · Real-Time Price · USD
2.300
-0.090 (-3.77%)
At close: Nov 13, 2026, 4:00 PM EST
2.280
-0.020 (-0.87%)
After-hours: Nov 13, 2026, 7:30 PM EST

Rocket Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-16.15-223.12-258.75-245.6-221.86-169.07
Depreciation & Amortization
8.511.039.387.16.275.37
Other Amortization
-----0.75
Loss (Gain) From Sale of Assets
-178.19-----
Asset Writedown & Restructuring Costs
0.260.26-0.890.240.26
Loss (Gain) From Sale of Investments
-3.91-6.97-8.07-10.170.132.89
Stock-Based Compensation
29.3837.0643.9239.4131.0129.24
Other Operating Activities
---1.88-0.36-12.78
Change in Accounts Payable
4.8-10.356.0710.159.67-4.83
Change in Other Net Operating Assets
-3.192.09-0.43.68-3.61.44
Operating Cash Flow
-158.9-190.01-209.72-194.92-178.14-121.16
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0.33-0.44-5.86-16.44-8.36-7.62
Cash Acquisitions
----42.73-
Investment in Securities
-33.64104.21137.57-81.59-103.4326.57
Other Investing Activities
----0.04-0.26-0.1
Investing Cash Flow
144.22103.77131.71-98.07-69.3318.85

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt Issued
33.98-----
Total Debt Repaid
-0.01-----
Net Debt Issued (Repaid)
33.97-----
Issuance of Common Stock
0.21-185.74208.4155.3437.68
Repurchase of Common Stock
--0.07---0.05-
Other Financing Activities
-0.22----
Financing Cash Flow
34.180.15185.74208.4155.2937.68

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
19.5-86.1107.72-84.58-92.18-64.63

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-159.23-190.45-215.59-211.35-186.5-128.78
Free Cash Flow Growth
------
Free Cash Flow Per Share
-1.41-1.71-2.27-2.52-2.74-2.04
Levered Free Cash Flow
99.06-104.85-133.26-119.77-99.45-82.57
Unlevered Free Cash Flow
100.24-103.67-132.08-118.6-98.29-81.47

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
-----0.15
Change in Working Capital
1.22-8.265.6713.826.08-3.39
SEC Filings: 10-K · 10-Q